Century Therapeutics, Inc. (IPSC)
Total Valuation
IPSC has a market cap or net worth of $567.91 million. The enterprise value is $229.62 million.
Market Cap | 567.91M |
Enterprise Value | 229.62M |
Important Dates
The next earnings date is Thursday, August 11, 2022, before market open.
Estimated Earnings Date | Aug 11, 2022 |
Ex-Dividend Date | n/a |
Share Statistics
IPSC has 58.85 million shares outstanding. The number of shares has increased by 643.13% in one year.
Shares Outstanding | 58.85M |
Shares Change (YoY) | +643.13% |
Shares Change (QoQ) | +76.13% |
Owned by Insiders (%) | 36.59% |
Owned by Institutions (%) | 60.16% |
Float | 20.32M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | 1.47 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 16.62, with a Debt / Equity ratio of 0.06.
Current Ratio | 16.62 |
Quick Ratio | 16.51 |
Debt / Equity | 0.06 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Financial Efficiency
Return on equity (ROE) is -27.80%, which is considered low. The company has a ROIC of -32.30%.
Return on Equity (ROE) | -27.80% |
Return on Assets (ROA) | -23.60% |
Return on Capital (ROIC) | -32.30% |
Revenue Per Employee | n/a |
Profits Per Employee | -$676,406 |
Employee Count | 170 |
Asset Turnover | 0.00 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, IPSC has paid $59,000 in taxes.
Income Tax | 59,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (1Y) | n/a |
Total Price Change | -64.76% |
50-Day Moving Average | 8.60 |
200-Day Moving Average | 11.79 |
Average Volume (30 Days) | 100,231 |
Short Selling Information
The latest short interest is 3.27 million, so 5.55% of the outstanding shares have been sold short.
Short Interest | 3.27M |
Short % of Shares Out | 5.55% |
Short % of Float | 16.08% |
Short Ratio (days to cover) | 44.76 |
Income Statement
Revenue | n/a |
Gross Profit | 1.06M |
Operating Income | -114.26M |
Pretax Income | -114.93M |
Net Income | -114.99M |
EBITDA | -108.67M |
EBIT | -113.66M |
Earnings Per Share (EPS) | -$2.57 |
Balance Sheet
The company has $362.74 million in cash and $24.45 million in debt, giving a net cash position of $338.29 million or $5.75 per share.
Cash & Cash Equivalents | 362.74M |
Total Debt | 24.45M |
Net Cash | 338.29M |
Net Cash Per Share | $5.75 |
Book Value | 386.66M |
Book Value Per Share | 6.57 |
Working Capital | 343.29M |
Cash Flow
In the last 12 months, operating cash flow was $19.93 million and capital expenditures -$47.15 million, giving a free cash flow of -$27.22 million.
Operating Cash Flow | 19.93M |
Capital Expenditures | -47.15M |
Free Cash Flow | -27.22M |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
IPSC does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Earnings Yield | -20.25% |
FCF Yield | -4.79% |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Buyback Yield | -643.13% |
Shareholder Yield | -643.13% |
Analyst Forecast
The average price target for IPSC is $25.70, which is 166.32% higher than the current price. The consensus rating is "Buy".
Price Target | $25.70 |
Price Target Difference | 166.32% |
Analyst Consensus | Buy |
Analyst Count | 12 |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |